Short answer
Agilent Technologies (A) filed its Q3 2026 10-Q quarterly report on Sep 1, 2026 for the quarter ended Jul 31, 2026. Quarterly revenue was $1.9B (up 8.1% year over year) with net income of $362M.
Q3 2026 key financials · XBRL
- Revenue
- $1.9B
- +8.1% YoY · +2.3% QoQ
- Net income
- $362M
- +7.7% YoY · +6.8% QoQ
- Operating margin
- 23.6%
- EPS (diluted)
- $1.28
- +7.6% YoY · +6.7% QoQ
Source: XBRL data from the Agilent Technologies (A) Q3 2026 10-Q on SEC EDGAR. USD.
Agilent Technologies Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1,878M, up 8% YoY from $1,738M
- Operating margin 23.6% vs 20.7% YoY; gross margin 55.5% vs 51.1%
- Best segment Life Sciences and Diagnostics Markets: $746M, up 11% YoY
- Operating cash flow $1,064M vs $1,014M; $78M share repurchases and $72M dividends
- Outlook: normalized customer capital budgets; tariff and Middle East risks remain dynamic
Risk Factors
- No explicit newly added risk identified; filing continues previously disclosed business, regulatory, and financial risks
- International exposure: foreign-exchange movements favorably affected revenue growth by 2 percentage points in nine months ended July 31, 2026
- Privacy compliance: GDPR violations can trigger fines of up to 4% of total company revenue
- Trade and geopolitical disruption: tariffs, sanctions, and export controls may restrict shipments and critical-component sourcing
- Demand volatility: customer orders remain difficult to forecast and may be delayed or cancelled during market declines
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Agilent Technologies quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.